92
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol

, , , , , , , , , , , , , & show all
Pages 1065-1072 | Published online: 12 Aug 2014

References

  • Zarogoulidis P Chatzaki E Porpodis K Inhaled chemotherapy in lung cancer: future concept of nanomedicine Int J Nanomedicine 2012 7 1551 1572 22619512
  • Zarogoulidis P Hohenforst-Schmidt W Darwiche K 2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy Gene Ther 2013 20 10 1022 1028 23719068
  • Zarogoulidis P Darwiche K Hohenforst-Schmidt W Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer Future Oncol 2013 9 8 1171 1194 23902248
  • Zarogoulidis P Eleftheriadou E Sapardanis I Feasibility and effectiveness of inhaled carboplatin in NSCLC patients Invest New Drugs 2012 30 4 1628 1640 21739158
  • Patel RB Smaldone GC Cuccia AD Strachan P In vitro delivery of aerosolized treprostinil via modern mechanical ventilation J Aerosol Med Pulm Drug Deliv 2013 26 4 200 207 23668545
  • Zarogoulidis P Kioumis I Ritzoulis C New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam Int J Pharm 2013 455 1–2 182 188 23891745
  • Zarogoulidis P Kioumis I Porpodis K Clinical experimentation with aerosol antibiotics: current and future methods of administration Drug Des Devel Ther 2013 7 1115 1134
  • Zarogoulidis P Darwiche K Yarmus L Defense mechanisms of the respiratory system and aerosol production systems Med Chem 2014 10 2 123 136 24007475
  • Miller JK Neubig R Clemons CB Nanoparticle deposition onto biofilms Ann Biomed Eng 2013 41 1 53 67 22878680
  • Ma B Darquenne C Aerosol deposition characteristics in distal acinar airways under cyclic breathing conditions J Appl Physiol (1985) 2011 110 5 1271 1282 21330617
  • Clay MM Pavia D Newman SP Clarke SW Factors influencing the size distribution of aerosols from jet nebulisers Thorax 1983 38 10 755 759 6648854
  • Newman SP Pellow PG Clay MM Clarke SW Evaluation of jet nebulisers for use with gentamicin solution Thorax 1985 40 9 671 676 4060108
  • Kendrick AH Smith EC Wilson RS Selecting and using nebuliser equipment Thorax 1997 52 Suppl 2 S92 S101 9155861
  • Kendrick AH Smith EC Denyer J Nebulizers – fill volume, residual volume and matching of nebulizer to compressor Respir Med 1995 89 3 157 159 7746906
  • Kwok PC Trietsch SJ Kumon M Chan HK Electrostatic charge characteristics of jet nebulized aerosols J Aerosol Med Pulm Drug Deliv 2010 23 3 149 159 20500092
  • Hoffmann N Duft D Kiselev A Leisner T Contact freezing efficiency of mineral dust aerosols studied in an electrodynamic balance: quantitative size and temperature dependence for illite particles Faraday Discuss 2013 165 383 390 24601013
  • Davis JM Davies IA Some physico-chemical characteristics of the antigens of Ehrlich ascites-tumour cells Biochem Soc Trans 1980 8 4 436 437 7450169
  • Buttini F Miozzi M Balducci AG Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers Int J Pharm 2014 465 1–2 42 51 24491530
  • Chen C Zhao B Cui W Dong L An N Ouyang X The effectiveness of an air cleaner in controlling droplet/aerosol particle dispersion emitted from a patient’s mouth in the indoor environment of dental clinics J R Soc Interface 2010 7 48 1105 1118 20031985
  • Lelong N Vecellio L Sommer de Gelicourt Y Tanguy C Diot P Junqua-Moullet A Comparison of numerical simulations to experiments for atomization in a jet nebulizer PLoS ONE 2013 8 11 e78659 24244334
  • Wu C Lee D Zachariah MR Aerosol-based self-assembly of nanoparticles into solid or hollow mesospheres Langmuir 2010 26 6 4327 4330 20041678
  • Labiris NR Dolovich MB Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications Br J Clin Pharmacol 2003 56 6 588 599 14616418
  • Zarogoulidis P Papanas N Kouliatsis G Spyratos D Zarogoulidis K Maltezos E Inhaled insulin: too soon to be forgotten? J Aerosol Med Pulm Drug Deliv 2011 24 5 213 223 21689020
  • Darwiche K Zarogoulidis P Karamanos NK Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology Future Oncol 2013 9 4 505 525 23560374
  • Zarogoulidis P Giraleli C Karamanos NK Inhaled chemotherapy in lung cancer: safety concerns of nanocomplexes delivered Ther Deliv 2012 3 9 1021 1023 23035587
  • Zarogoulidis P Petridis D Ritzoulis C Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics Int J Pharm 2013 456 2 325 331 24035789
  • Zarogoulidis P Darwiche K Huang H Time recall; future concept of chronomodulating chemotherapy for cancer Curr Pharm Biotechnol 2013 14 6 632 642 24180308
  • Zaric B Stojsic V Tepavac A Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC) J Thorac Dis 2013 5 Suppl 4 S371 S377 24102009
  • Boukovinas I Tsakiridis K Zarogoulidis P Neo-adjuvant chemotherapy in early stage non-small cell lung cancer J Thorac Dis 2013 5 Suppl 4 S446 S448 24102019
  • Maiz L Canton R Mir N Baquero F Escobar H Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis Pediatr Pulmonol 1998 26 4 287 289 9811080
  • Park CW Li X Vogt FG Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols Int J Pharm 2013 455 1–2 374 392 23820131
  • Nettey H Haswani D Oettinger CW D’Souza MJ Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying J Microencapsul 2006 23 6 632 642 17118879
  • Zarogoulidis P Petridis D Ritzoulis C Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays’ production systems Int J Pharm 2013 458 1 39 47 24140545
  • Prober CG Walson PD Jones J Committee on Infectious Diseases and Committee on Drugs Technical report: precautions regarding the use of aerosolized antibiotics Pediatrics 2000 106 6 E89 11099632
  • Swaney SM Aoki H Ganoza MC Shinabarger DL The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria Antimicrob Agents Chemother 1998 42 12 3251 3255 9835522
  • Brickner SJ Hutchinson DK Barbachyn MR Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections J Med Chem 1996 39 3 673 679 8576909
  • Moellering RCJr Vancomycin: a 50-year reassessment Clin Infect Dis 2006 42 Suppl 1 S3 S4 16323117
  • Baltz RH Daptomycin: mechanisms of action and resistance, and biosynthetic engineering Curr Opin Chem Biol 2009 13 2 144 151 19303806
  • Henken S Bohling J Martens-Lobenhoffer J Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae Antimicrob Agents Chemother 2010 54 2 707 717 19917756